Predictive models for all-cause and cardiovascular mortality in type 2 diabetic inpatients. A cohort study

Summary Background Many authors have analysed premature mortality in cohorts of type 2 diabetic patients, but no analyses have assessed mortality in hospitalised diabetic patients. Aim To construct predictive models to estimate the likelihood of all‐cause mortality and cardiovascular mortality in ty...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical practice (Esher) 2015-04, Vol.69 (4), p.474-484
Hauptverfasser: Ramírez-Prado, D., Palazón-Bru, A., Folgado-de-la Rosa, D. M., Carbonell-Torregrosa, M. Á., Martínez-Díaz, A. M., Gil-Guillén, V. F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background Many authors have analysed premature mortality in cohorts of type 2 diabetic patients, but no analyses have assessed mortality in hospitalised diabetic patients. Aim To construct predictive models to estimate the likelihood of all‐cause mortality and cardiovascular mortality in type 2 diabetic inpatients. Design Cohort study with follow‐up from 2010 to 2014. Methods We evaluated mortality in a randomly selected cohort of 112 type 2 diabetic inpatients at the Hospital of Elda (Spain) in 2010–2012. Outcomes: all‐cause mortality and cardiovascular mortality during the follow‐up. Other variables: gender, age, depression, asthma/chronic obstructive pulmonary disease, hypertension, dyslipidemia, insulin, pills, smoking, walking, baseline blood glucose and creatinine. Predictive tables with risk groups were constructed to estimate the likelihood of all‐cause mortality and cardiovascular mortality. Calculations were made of the area under the ROC curve (AUC). Results During the follow‐up, 52 inpatients died (46.4%, 95% CI, confidence interval: 37.2–55.7%), 22 because of cardiovascular causes (19.6%, 95% CI: 12.3–27.0%). The mean follow‐up time was 2.7 ± 1.5 years. The AUC for the all‐cause mortality model was 0.84 (95% CI: 0.77–0.92, p 
ISSN:1368-5031
1742-1241
DOI:10.1111/ijcp.12563